A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

IsraelRecruitingPHASE3

Conditions

Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham ( Site 0006), Birmingham, Alabama, United States

    Study coordinator · (205) 934-7442
  • Alaska Women's Cancer Care ( Site 0096), Anchorage, Alaska, United States

    Study coordinator · 907-562-4673
  • Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven, Connecticut, United States

    Study coordinator · 203-785-5702
  • Mount Sinai Cancer Center ( Site 0078), Miami Beach, Florida, United States

    Study coordinator · 305-674-2625
  • Sarasota Memorial Hospital ( Site 0075), Sarasota, Florida, United States

    Study coordinator · 941-917-2225
  • Florida Cancer Specialists East ( Site 7000), West Palm Beach, Florida, United States

    Study coordinator · 561-366-4100
  • Winship Cancer Institute of Emory University ( Site 0086), Atlanta, Georgia, United States

    Study coordinator · 404-778-1900
  • Augusta University - Georgia Cancer Center ( Site 0066), Augusta, Georgia, United States

    Study coordinator · 706-721-6744
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0003), Fort Wayne, Indiana, United States

    Study coordinator · 260-425-6981
  • Women's Cancer Care ( Site 0067), Covington, Louisiana, United States

    Study coordinator · 985-892-2252
  • Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0008), Scarborough, Maine, United States

    Study coordinator · 207-883-0069
  • St. Dominic's Hospital ( Site 0064), Jackson, Mississippi, United States

  • Nebraska Methodist Hospital ( Site 0053), Omaha, Nebraska, United States

    Study coordinator · 402-354-8534
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0081), Hackensack, New Jersey, United States

    Study coordinator · 551-996-5855
  • Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick, New Jersey, United States

    Study coordinator · 732-235-7258
  • University of New Mexico Comprehensive Cancer Center ( Site 0055), Albuquerque, New Mexico, United States

    Study coordinator · 505-272-4946
  • NYU Langone Hospital - Long Island ( Site 0015), Mineola, New York, United States

    Study coordinator · 516-663-0333
  • Laura and Isaac Perlmutter Cancer Center ( Site 0076), New York, New York, United States

    Study coordinator · 212-731-6000
  • FirstHealth Cancer Center ( Site 0079), Pinehurst, North Carolina, United States

    Study coordinator · 910-715-8684
  • University of Cincinnati Medical Center ( Site 0090), Cincinnati, Ohio, United States

    Study coordinator · 513-584-1958
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0054), Columbus, Ohio, United States

    Study coordinator · 614-293-3300
  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0056), Tulsa, Oklahoma, United States

    Study coordinator · 918-505-3200
  • Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8010), Eugene, Oregon, United States

    Study coordinator · 541-683-5001
  • Women & Infants Hospital ( Site 0050), Providence, Rhode Island, United States

    Study coordinator · 401-274-1100
  • Henry-Joyce Cancer Clinic ( Site 0060), Nashville, Tennessee, United States

    Study coordinator · 615-936-8422
  • Texas Oncology - Central/South Texas ( Site 8009), Austin, Texas, United States

    Study coordinator · 512-873-8900
  • Texas Oncology - DFW ( Site 8001), Fort Worth, Texas, United States

    Study coordinator · 817-413-1500
  • Texas Oncology - San Antonio ( Site 8005), San Antonio, Texas, United States

    Study coordinator · 210-595-5300
  • Texas Oncology - Gulf Coast ( Site 8003), Webster, Texas, United States

    Study coordinator · 281-332-7505
  • Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax, Virginia, United States

    Study coordinator · (571) 350-8400
  • Instituto Alexander Fleming ( Site 2909), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · 5411 3221 8900
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 2901), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +54 223 496 3224
  • Fundación Respirar ( Site 2912), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +5491167281601
  • Instituto de Oncologia de Rosario ( Site 2910), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414218909
  • Hospital Aleman ( Site 2903), CABA, Argentina

    Study coordinator · +541148277000
  • Hospital Italiano de Cordoba ( Site 2908), Córdoba, Argentina

    Study coordinator · +543517078224
  • Blacktown Hospital ( Site 0211), Sydney, New South Wales, Australia

    Study coordinator · +61286705071
  • Gallipoli Medical Research Ltd ( Site 0214), Brisbane, Queensland, Australia

    Study coordinator · +61733947284
  • Epworth Freemasons ( Site 0217), East Melbourne, Victoria, Australia

    Study coordinator · +61385595000
  • Frankston Hospital ( Site 0216), Frankston, Victoria, Australia

    Study coordinator · +61409848084
  • Antwerp University Hospital ( Site 0304), Edegem, Antwerpen, Belgium

    Study coordinator · + 32 3 821 47 19
  • Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0306), Liège, Liege, Belgium

    Study coordinator · +32 4 323 5332
  • AZ Sint-Lucas ( Site 0305), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 9 224 66 20
  • CHU UCL Namur/Site Sainte Elisabeth ( Site 0302), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 (0)81 70 28 44
  • UZ Leuven ( Site 0301), Leuven, Vlaams-Brabant, Belgium

    Study coordinator · +32 16 34 74 19
  • Liga Norte Riograndense Contra o Cancer ( Site 0423), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +558440095600
  • Hospital São Lucas da PUCRS ( Site 0425), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133203000
  • ANIMI - Unidade de Tratamento Oncologico ( Site 0419), Lages, Santa Catarina, Brazil

    Study coordinator · +554933805200
  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0413), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 17 32015054
  • Hospital Paulistano ( Site 0421), São Paulo, Brazil

    Study coordinator · +551130161000
  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0424), São Paulo, Brazil

    Study coordinator · +551134744264
  • Princess Margaret Cancer Centre ( Site 0518), Toronto, Ontario, Canada

    Study coordinator · (416) 946-4501
  • McGill University Health Centre ( Site 0502), Montreal, Quebec, Canada

    Study coordinator · 514-934-1934
  • Clinica Puerto Montt ( Site 0615), Port Montt, Los Lagos Region, Chile

    Study coordinator · 56961687093
  • ONCOCENTRO APYS-ACEREY ( Site 0612), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56323320860
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0806), Bogotá, Bogota D.C., Colombia

    Study coordinator · +576015948650
  • Instituto Nacional De Cancerologia ( Site 0807), Bogotá, Bogota D.C., Colombia

    Study coordinator · +573154208007
  • Oncologos Del Occidente ( Site 0805), Pereira, Risaralda Department, Colombia

    Study coordinator · +57 3187715522
  • Fakultni nemocnice Ostrava ( Site 3323), Ostrava-Poruba, Ostrava Mesto, Czechia

    Study coordinator · +420597371804
  • Vseobecna fakultni nemocnice v Praze ( Site 3325), Prague, Czechia

    Study coordinator · +420224967451
  • Fakultni nemocnice v Motole ( Site 3322), Prague, Czechia

    Study coordinator · +420224434749
  • Rigshospitalet ( Site 0904), Copenhagen, Capital Region, Denmark

    Study coordinator · +45 35453545
  • Herlev Hospital ( Site 0903), Herlev, Capital Region, Denmark

    Study coordinator · +45 38683868
  • Aalborg Universitetshospital ( Site 0901), Aalborg, North Denmark, Denmark

    Study coordinator · 97661400
  • Vejle Sygehus ( Site 0902), Vejle, Region Syddanmark, Denmark

    Study coordinator · 79406088
  • Oulun yliopistollinen sairaala ( Site 1003), Oulu, North Ostrobothnia, Finland

    Study coordinator · +358505794505
  • Kuopion Yliopistollinen Sairaala ( Site 1004), Kuopio, Northern Savonia, Finland

    Study coordinator · +358447174617
  • Tampereen yliopistollinen sairaala ( Site 1002), Tampere, Pirkanmaa, Finland

    Study coordinator · +358407274241
  • Centre Oscar Lambret ( Site 1104), Lille, Ain, France

    Study coordinator · +33320295959
  • Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 1101), Bordeaux, Aquitaine, France

    Study coordinator · +33556333333
  • Centre Hopitalier Lyon Sud ( Site 1110), Pierre-Bénite, Auvergne-Rhône-Alpes, France

    Study coordinator · +33478864318
  • Centre Francois Baclesse ( Site 1108), Caen, Calvados, France

    Study coordinator · +33231459700
  • Hôpital Privé Des Côtes d'Armor ( Site 1106), Plérin, Cotes-d Armor, France

    Study coordinator · +33257240243
  • Oncopole Claudius Regaud ( Site 1109), Toulouse, Haute-Garonne, France

    Study coordinator · +33531155101
  • Pôle Santé Léonard de Vinci ( Site 1112), Chambray-lès-Tours, Indre-et-Loire, France

    Study coordinator · +33247602060
  • Groupe Hospitalier Broca Cochin Hotel Dieu ( Site 1111), Paris, Paris, France

    Study coordinator · +33158411439
  • Institut De Cancerologie De L Ouest ( Site 1107), Saint-Herblain, Pays de la Loire Region, France

    Study coordinator · +33 2 40 67 99 00
  • Sainte Catherine Institut du Cancer Avignon Provence ( Site 1105), Avignon, Vaucluse, France

    Study coordinator · +33490276161
  • Groupe Hospitalier Diaconesses Croix Saint Simon ( Site 1102), Paris, France

    Study coordinator · +33 1 44 74 11 53
  • Aretaieio Hospital ( Site 0701), Athens, Attica, Greece

    Study coordinator · +302107286444
  • ATTIKON GENERAL UNIVERSITY HOSPITAL-Oncology ( Site 0702), Chaïdári, Attica, Greece

    Study coordinator · +302105831643
  • Bacs-Kiskun Megyei Korhaz ( Site 3920), Kecskemét, Bács-Kiskun county, Hungary

    Study coordinator · +3676516719
  • Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterapias Klinika ( Site 3924), Szeged, Csongrád megye, Hungary

    Study coordinator · +36 62 544 596
  • Debreceni Egyetem Klinikai Kozpont ( Site 3922), Debrecen, Hajdú-Bihar, Hungary

    Study coordinator · 0652255705
  • Országos Onkológiai Intézet-Ngyógyászat ( Site 3923), Budapest, Pest County, Hungary

    Study coordinator · +3612248600 Ext 3616
  • St James Hospital ( Site 1301), Dublin, Ireland

    Study coordinator · +35314103747
  • Hillel Yaffe Medical Center ( Site 1404), Hadera, Israel

    Study coordinator · +972544512396
  • Rambam Health Care Campus ( Site 1402), Haifa, Israel

    Study coordinator · +97247772688
  • Shaare Zedek Medical Center ( Site 1405), Jerusalem, Israel

    Study coordinator · +97226555424
  • Meir Medical Center. ( Site 1403), Kfar Saba, Israel

    Study coordinator · 972-9-7471575
  • Sheba Medical Center ( Site 1401), Ramat Gan, Israel

    Study coordinator · 972-3-5303157
  • CRO-IRCCS ( Site 1510), Aviano, Friuli Venezia Giulia, Italy

    Study coordinator · +390434659474
  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1507), Milan, Milano, Italy

    Study coordinator · 39 0223903479
  • Azienda Ospedaliero Universitaria Pisana ( Site 1504), Pisa, Tuscany, Italy

    Study coordinator · +39050992371
  • Instituto Tumori Giovanni Paolo II ( Site 1505), Bari, Italy

    Study coordinator · +390805555355
  • Istituto Ospedaliero,Fondazione Poliambulanza ( Site 1511), Brescia, Italy

    Study coordinator · +390303518503
  • Istituto Europeo di Oncologia ( Site 1506), Milan, Italy

    Study coordinator · +390257482540
  • Humanitas San Pio X Hospital ( Site 1503), Milan, Italy

    Study coordinator · +390269516354
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1501), Naples, Italy

    Study coordinator · +390815903637
  • Istituto Oncologico Veneto IRCCS ( Site 1508), Padova, Italy

    Study coordinator · +390498215729
  • Fondazione Policlinico Universitario Agostino Gemelli ( Site 1502), Roma, Italy

    Study coordinator · +390630157004
  • Ospedale Mauriziano ( Site 1509), Torino, Italy

    Study coordinator · +39 0115082277
  • Aichi Cancer Center ( Site 1626), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111
  • National Hospital Organization Shikoku Cancer Center ( Site 1631), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Ehime University Hospital ( Site 1637), Tōon, Ehime, Japan

    Study coordinator · +81-89-964-5111
  • Kurume University Hospital ( Site 1640), Kurume, Fukuoka, Japan

    Study coordinator · +81-942-35-3311
  • Gunma Prefectural Cancer Center ( Site 1630), Ōta, Gunma, Japan

    Study coordinator · +81-276-38-0771
  • Hokkaido University Hospital ( Site 1634), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161
  • Iwate Medical University Hospital ( Site 1635), Shiwa-gun, Iwate, Japan

    Study coordinator · +81-19-613-7111
  • Saitama Medical University International Medical Center ( Site 1632), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Cancer Institute Hospital of JFCR ( Site 1639), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Keio University Hospital ( Site 1636), Shinjyuku, Tokyo, Japan

    Study coordinator · +81-3-3353-1211
  • National Hospital Organization Kyushu Cancer Center ( Site 1628), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Kagoshima City Hospital ( Site 1638), Kagoshima, Japan

    Study coordinator · +81-99-230-7000
  • Niigata Cancer Center Hospital ( Site 1633), Niigata, Japan

    Study coordinator · +81-25-266-5111
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1629), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 1719), Guadalajara, Jalisco, Mexico

    Study coordinator · +523313587270
  • Higiea Oncologia ( Site 1713), Mexico City, Mexico City, Mexico

    Study coordinator · +525579389376
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 1711), Monterrey, Nuevo León, Mexico

    Study coordinator · +528115443345
  • I CAN ONCOLOGY CENTER S.A. DE C.V. ( Site 1716), Monterrey, Nuevo León, Mexico

    Study coordinator · +528125558165
  • Servicios de Oncología Médica Integral - Monterrey ( Site 1712), Monterrey, Nuevo León, Mexico

    Study coordinator · +5218118213989
  • Centro de Investigación Oncológica Galerías SC ( Site 1720), Aguascalientes, Mexico

    Study coordinator · +525527280926
  • Cryptex Investigación Clínica S.A. de C.V. ( Site 1715), Cuauhtémoc, Mexico

    Study coordinator · +525555743589
  • COI Centro Oncologico Internacional S.A.P.I. de C.V. ( Site 1717), Mexico City, Mexico

    Study coordinator · +525554248970x4016
  • Centro de Investigacion Clinica de Oaxaca ( Site 1714), Oaxaca City, Mexico

    Study coordinator · +529516035559
  • Unidad de Investigacion Oncologia Clínica Piura ( Site 3606), Castilla, Piura, Peru

    Study coordinator · +51969618109
  • Hospital Guillermo Almenara Irigoyen ( Site 3608), Lima, Peru

    Study coordinator · +51999903343
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 3604), Lima, Peru

    Study coordinator · +51 951 881 870
  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 3601), Lima, Peru

    Study coordinator · +51 940 238 282
  • Clínica San Felipe ( Site 3603), Lima, Peru

    Study coordinator · +5112190000 Ext 8327
  • Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2106), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48618549049
  • Bialostockie Centrum Onkologii ( Site 2104), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · 0048856646728
  • Swietokrzyskie Centrum Onkologii. ( Site 2105), Kielce, Świętokrzyskie Voivodeship, Poland

    Study coordinator · 0048413674128
  • Hospital da Luz ( Site 3802), Lisbon, Portugal

    Study coordinator · +351217104400
  • Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 3801), Porto, Portugal

    Study coordinator · +351225084000
  • Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2215), Cluj-Napoca, Cluj, Romania

    Study coordinator · +40264598362
  • S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2211), Craiova, Dolj, Romania

    Study coordinator · +40731604432
  • Cabinet Medical Oncomed ( Site 2217), Timișoara, Timiș County, Romania

    Study coordinator · +40256495403
  • Spitalul Clinic Filantropia ( Site 2213), Bucharest, Romania

    Study coordinator · +40213188930
  • National Cancer Center ( Site 2305), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · 82-31-920-1760
  • Severance Hospital ( Site 2302), Seodaemun-Gu, Seoul, South Korea

    Study coordinator · 82-2-2227-7969
  • Asan Medical Center ( Site 2304), Songpa-gu, Seoul, South Korea

    Study coordinator · +82-2-3010-3640
  • Seoul National University Hospital ( Site 2301), Seoul, South Korea

    Study coordinator · 82-2-2072-3511
  • Samsung Medical Center ( Site 2303), Seoul, South Korea

    Study coordinator · 82-2-3410-0866
  • Institut Català d'Oncologia (ICO) - Girona ( Site 2402), Girona, Gerona, Spain

    Study coordinator · +34972225828
  • Hospital General Gregorio Maranon de Madrid ( Site 2412), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34915860860
  • Clinica Universidad de Navarra ( Site 2407), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34913531920
  • Hosp Clinico Universitario de Valencia ( Site 2401), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · 34 961973500
  • Hospital Vall D Hebron ( Site 2403), Barcelona, Spain

    Study coordinator · +34932746085
  • Hospital Clinic I Provincial de Barcelona ( Site 2409), Barcelona, Spain

    Study coordinator · 34932275402
  • ICO L Hospitalet ( Site 2408), Barcelona, Spain

    Study coordinator · +34932607744
  • Hospital Universitario Reina Sofia ( Site 2406), Córdoba, Spain

    Study coordinator · +34957011464
  • Hospital Ramon y Cajal ( Site 2405), Madrid, Spain

    Study coordinator · +3491336 82 63
  • Hospital Clinico San Carlos... ( Site 2410), Madrid, Spain

    Study coordinator · 34 913303000 x484811
  • Hospital Universitario 12 de Octubre ( Site 2411), Madrid, Spain

    Study coordinator · +34913908626
  • Hospital Universitario La Paz ( Site 2404), Madrid, Spain

    Study coordinator · +34 679927508
  • Taichung Veterans General Hospital ( Site 2603), Taichung, Taiwan

    Study coordinator · 886423592525x5822
  • National Cheng Kung University Hospital ( Site 2602), Tainan, Taiwan

    Study coordinator · +88662353535x5222
  • National Taiwan University Hospital ( Site 2601), Taipei, Taiwan

    Study coordinator · 886-223123456x271563
  • Mackay Memorial Hospital ( Site 2604), Taipei, Taiwan

    Study coordinator · +886225433535x3941
  • Chang Gung Memorial Hospital - Linkou Branch ( Site 2605), Taoyuan, Taiwan

    Study coordinator · +886-33281200x8258
  • Ramathibodi Hospital ( Site 3402), Bangkok, Bangkok, Thailand

    Study coordinator · +6622011451
  • Faculty of Medicine Siriraj Hospital ( Site 3401), Bangkok, Bangkok, Thailand

    Study coordinator · +6624194685
  • Cambridge University Hospital ( Site 2803), Cambridge, Cambridgeshire, United Kingdom

    Study coordinator · 01223 216083
  • Western General Hospital ( Site 2806), Edinburgh, Edinburgh, City of, United Kingdom

    Study coordinator · +441315371000
  • ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 2801), London, London, City of, United Kingdom

    Study coordinator · 02089156899
  • Royal Marsden Hospital (Sutton) ( Site 2802), Sutton, London, City of, United Kingdom

    Study coordinator · 02089156899
  • Leicester Royal Infirmary ( Site 2808), Leicester, United Kingdom

    Study coordinator · 0300 303 1573
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC